REDUCED PERFUSION ON NITRATE ENHANCED STUDY COMPARED TO RESTING WITH 99mTc-SESTAMIBI IMAGING FOR MYOCARDIAL VIABILITY

Authors

  • Asif Jielani INSTITUTE OF NUCLEAR MEDICINE, ONCOLOGY AND RADIOTHERAPY (INOR)
  • Mausab Riaz
  • Muhammad Anees

Abstract

Patients with ischemic heart disease and left ventricular dysfunction need evaluation for myocardial viability. Two cases of myocardial perfusion imaging for viability study are discussed. Viability imaging is performed with 99mTc-Sestamibi (99mTc-MIBI), acquiring images with and without nitrate enhancement. Improvement in perfusion in nitrate enhanced images is suggestive of myocardial viability. In these cases, there was paradox effect showing reduced uptake on nitrate enhanced images than on resting images. Technical factors of equal radiotracer dose in both studies, pre-imaging time and processing were considered. Since no such contributing factor was delineated, it is postulated that phenomena can occur due to differential effects of oral glyceryl triglyceryl trinitrate (GTN) on normal and diseased vessels. Keywords: Myocardial viability, Glyceryl trinitrate,99mTc-Sestamibi, Radiotracers

References

Yang, Min-Fu; Keng, Felix; He, Zuo-Xiang, Nitrate augmented myocardial perfusion imaging for assessment of myocardial viability: recent advances. Nuclear Medicine Communications: June 2009 - Volume 30 - Issue 6 - p 415-419

Sciagra R, Pellegri M, Pupi A, Bolognese L, Bisi G, Carnovale V, et al. Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 2000; 36: 739–745

Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002; 39:1151–1158.

Senior R, Kaul S, Raval U, Lahiri A (2002) Impact of revascularization and myocardial viability determined by nitrate-enhanced Tc-99m mibi and Tl-201 imaging on mortality and functional outcome in ischemic cardiomyopathy. J Nucl Cardiol 9: 454-462.

Basu S, Senior R, Raval U, Lahiri A (1997) Superiority of nitrate-enhanced 201Tl over conventional redistribution 201Tl imaging for prognostic evaluation after myocardial infarction and thrombolysis. Circulation 96: 2932-2937.

Abrams J. Mechanisms of action of the organic nitrates in the treatment of myocardial ischemia. Am J Cardiol. 1992;70:30B–42B.

Brown BG, Bolson E, Petersen RB, Pierce CD, Dodge HT. The mechanisms of nitroglycerin action: stenosis vasodilatation as a major component of the drug response. Circulation. 1981;64:1089– 1097.

Rizzello V, Poldermans D, Bax JJ. Assessment of myocardial viability in chronic ischemic heart disease: current status. Q J Nucl Med Mol Imaging. 2005; 49:81–96.

Ragosta M, Beller GA. The noninvasive assessment of myocardial viability. Clin Cardiol. 1993;16(7):531–538.

Bøttcher M, Madsen MM, Randsbaek F, Refsgaard J, Dørup I, Sørensen K, et al. Effect of oral nitroglycerin and cold stress on myocardial perfusion in areas subtended by stenosed and nonstenosed coronary arteries. Am J Cardiol 2002;89:1019‑24.

Niyaz K, Niaz K, Zaman MU, Kamal S, Usmani S, Habib S, et al. Assessment of viable myocardium by nitrate augmented 99mTc MIBI myocardial perfusion imaging. J Pak Med Assoc 2007;57:83‑7.1. Yang MF, Keng F, He ZX. Glyceryl trinitrate augmented myocardial perfusion imaging for assessment of myocardial viability: recent advances. Nucl Med Commun 2009;30(6):415–9.

Sciagra R, Pellegri M, Pupi A, Bolognese L, Bisi G, Carnovale V, et al. Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 2000;36(3):739–45.

Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39(7):1151–8.

Senior R, Kaul S, Raval U, Lahiri A. Impact of revascularization and myocardial viability determined by glyceryl trinitrate-enhanced Tc-99m mibi and Tl-201 imaging on mortality and functional outcome in ischemic cardiomyopathy. J Nucl Cardiol 2002;9(5):454–62.

Basu S, Senior R, Raval U, Lahiri A. Superiority of glyceryl trinitrate-enhanced 201Tl over conventional redistribution 201Tl imaging for prognostic evaluation after myocardial infarction and thrombolysis. Circulation 1997;96(9):2932–7.

Abrams J. Mechanisms of action of the organic glyceryl trinitrates in the treatment of myocardial ischemia. Am J Cardiol 1992;70(8):30B–42.

Brown BG, Bolson E, Petersen RB, Pierce CD, Dodge HT. The mechanisms of nitroglycerin action: stenosis vasodilatation as a major component of the drug response. Circulation 1981;64(6):1089–97.

Rizzello V, Poldermans D, Bax JJ. Assessment of myocardial viability in chronic ischemic heart disease: current status. Q J Nucl Med Mol Imaging 2005;49(1):81–96.

Ragosta M, Beller GA. The noninvasive assessment of myocardial viability. Clin Cardiol 1993;16(7):531–8.

Bøttcher M, Madsen MM, Randsbaek F, Refsgaard J, Dørup I, Sørensen K, et al. Effect of oral nitroglycerin and cold stress on myocardial perfusion in areas subtended by stenosed and nonstenosed coronary arteries. Am J Cardiol 2002;8(9):1019–24.

Niyaz K, Niaz K, Zaman MU, Kamal S, Usmani S, Habib S, et al. Assessment of viable myocardium by glyceryl trinitrate augmented 99mTc MIBI myocardial perfusion imaging. J Pak Med Assoc 2007;57:83–7.

Published

2020-07-15

Most read articles by the same author(s)